CNBX Pharmaceuticals Inc.
CNBX
$0.0022
$0.000210.00%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.80K | -34.40K | -60.60K | -130.60K | -325.50K |
| Total Depreciation and Amortization | -- | -- | 0.00 | 0.00 | 32.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.20K | 3.10K | 35.00K | 0.00 | 164.00K |
| Change in Net Operating Assets | 13.90K | -7.80K | -22.60K | 130.80K | 4.20K |
| Cash from Operations | -51.70K | -39.10K | -48.30K | 200.00 | -124.40K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 94.70K | 20.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 94.70K | 20.00K |
| Total Debt Issued | 80.00K | 30.00K | 1.30K | 1.30K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 80.00K | 30.00K | 1.30K | 1.30K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -59.90K | 59.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.30K | -9.10K | -47.00K | 36.30K | -44.50K |